Screener
Bio-Rad Laboratories BIO Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | March 31, 2026 | March 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $507.2 | $521.4 |
| Restricted cash included in Other current assets | 1.6 | 1.3 |
| Restricted cash included in Other assets | 0.2 | 0.4 |
| Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows | $509.0 | $523.1 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's restricted cash?
- Bio-Rad Laboratories (BIO) reported restricted cash of $1.6M in Q1 2026.
- How has Bio-Rad Laboratories's restricted cash changed year-over-year?
- Bio-Rad Laboratories's restricted cash increased by 23.1% year-over-year, from $1.3M to $1.6M.
- What is the long-term trend for Bio-Rad Laboratories's restricted cash?
- Over 2 years (2022 to 2024), Bio-Rad Laboratories's restricted cash has grown at a -100.0% compound annual growth rate (CAGR), from $5.56M to $0.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Bio-Rad Laboratories's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude